This study looks at a new medicine, EC5026, to help with neuropathic pain (pain from nerve damage) in people with spinal cord injuries. The study checks if EC5026 is safe and helps with pain. Participants will take either EC5026 or a placebo (a harmless pill that looks the same) every day for 14 days without knowing which one they are taking. They will have regular check-ups, including physical exams, heart tests (ECGs), and blood tests. They will also answer questions about their pain, sleep, and how they feel over time.

Key Points:

• Study Duration: 14 days of taking medicine daily.
• Eligibility: Adults with spinal cord injury pain, able to visit the study site daily.
• Participation: Includes physical exams and answering questions about health and pain.

Eligibility requires participants to be at least 18 years old, have a spinal cord injury with pain, and not require a ventilator. They should have tried at least two other pain treatments without success. Those with certain health problems or on some medications may not join. Participants must be able to travel to the study site daily and understand English.